Skip Navigation
Explore our COVID-19 Resources and Updates
CHS blue logo square
Home > News > Center News > 2009

Center News

Thomas V. Inglesby Named Director of UPMC’s Center for Biosecurity

August 7, 2009—The University of Pittsburgh Medical Center announced today that Thomas V. Inglesby, MD, is the new director and chief executive officer of the Center for Biosecurity of UPMC in Baltimore. He succeeds Tara O’Toole, MD, MPH, who was recently appointed Under Secretary for Science & Technology in the Department of Homeland Security.

Dr. Inglesby has been the chief operating officer and deputy director of the Center for Biosecurity since its founding in 2003 and is an associate professor of medicine and public health at the University of Pittsburgh School of Medicine and Graduate School of Public Health. An infectious diseases physician by training, Dr. Inglesby was one of the founding members of the Johns Hopkins Center for Civilian Biodefense Strategies, where he was the deputy director from 2001 to 2003.

“Tom’s extraordinary expertise and profound knowledge of biosecurity issues uniquely qualify him for this new role,” said Jeffrey A. Romoff, president and chief executive officer of UPMC. “We live in an era when bioterrorism, pandemic influenza, and other global health issues require us to think and act creatively, and his capable leadership will keep the Center at the forefront of that effort.”

Dr. Inglesby has been an advisor to numerous government, scientific, and academic organizations on issues related to biosecurity. He has served on committees of the Defense Science Board and the National Research Council of the National Academies of Sciences, and, most recently, he was appointed to the Technical Committee on National Health Security Strategy (HHS) and as a member of the Maryland Governor’s H1N1 Flu Advisory Board.

Dr. Inglesby was a principal designer, author, and controller of the widely recognized Atlantic Storm exercise of 2005 and of the Dark Winter smallpox exercise of 2001. He is coeditor-in-chief of the peer-reviewed journal Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science and has authored a number of widely cited publications on anthrax, smallpox, and plague and on a range of biosecurity issues including medicine and hospital preparedness, scientific research strategy, pandemic response, and national security.

“Building on the Center’s already strong foundation, it is my intention that the Center will continue to provide insightful, constructive, and respected policy analysis and practical recommendations aimed at preventing and mitigating the effects of biological threats and other serious health challenges,” said Dr. Inglesby. “I will place a particular priority on improving the nation’s response to H1N1, on strategies to address the evolving biological weapons threat, and on international partnerships to confront these issues.” 

The Center for Biosecurity is an independent, nonprofit organization of the University of Pittsburgh Medical Center (UPMC) whose mission is to strengthen national security by reducing the risks posed by biological attacks, epidemics, and other destabilizing events, and to improve the nation’s resilience in the face of such events.

UPMC is an $8 billion integrated global health enterprise headquartered in Pittsburgh and one of the leading nonprofit health systems in the United States. As western Pennsylvania’s largest employer, with 50,000 employees, UPMC is transforming the economy of the region into one based on medicine, research, and technology. By integrating 20 hospitals, 400 doctors’ offices and outpatient sites, long-term care facilities, and a major health insurance services division, and in collaboration with its academic partner, the University of Pittsburgh Schools of the Health Sciences, UPMC has advanced the quality and efficiency of health care and developed internationally renowned programs in transplantation, cancer, neurosurgery, psychiatry, orthopedics, and sports medicine, among others. UPMC is commercializing its medical and technological expertise by nurturing new companies, developing strategic business relationships with some of the world’s leading multinational corporations, and expanding into international markets, including Italy, Ireland, the United Kingdom, Cyprus, and Qatar. For more information about UPMC, visit our website at





Our Mission

To protect people’s health from epidemics and disasters and ensure that communities are resilient to major challenges.